FDA Inspection
Turbare ManufacturingTurbare Manufacturing – FDA Inspection, May 7, 2026
Record Details
This FDA Inspection record concerns Turbare Manufacturing, with an inspection on May 7, 2026, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 0791d146-5976-48e8-aa95-841b58fe4aa8
Inspection Facts
- Inspection number
- 1305264
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.28(b)Habits of good sanitation & health
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Turbare Manufacturing
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 24, 2025 | OAI | Dallas District Office | Drug Quality Assurance |
Other documents for Turbare Manufacturing
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.